AstraZeneca announced that its CEO, Pascal Soriot, earned £17.7 million in 2025, an increase of over 6% compared to 2024, when he earned £16.6 million. This includes annual bonuses of £4.3 million and long-term shares worth £11.6 million. The company reported a profit increase of 40% and a rise in shares over the last 12 months, and Soriot could benefit from an additional salary increase in 2026, with a possible maximum package of £19.6 million. Although AstraZeneca is expanding its operations in the US and China and investing in weight loss drugs, it has reduced investments in the UK, canceling a £450 million expansion for a vaccine facility last year. Soriot has consistently been named the highest-paid CEO in the UK, earning 176 times the average salary of an AstraZeneca employee.
Sources
Latest News
09:21
The Niculescu Government takes the first step toward unblocking sheep exports / The first 300,000 doses have already arrived in Romania
09:19
South African author published 371 books with the help of artificial intelligence
09:14
Presidential elections in Brazil / A poll puts Lula and Bolsonaro in a tie
08:46
Tom Skerritt, an actor known from films such as “MASH,” “Top Gun,” “Alien,” and “Steel Magnolias,” has died at the age of 93
08:29
Ludovic Orban, reaction to the SRI statement / In practice, the intelligence services are completely beyond the control of civil society
See more news